Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes
- 21 June 2012
- journal article
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 67 (2), 140-146
- https://doi.org/10.1016/j.jdermsci.2012.05.008
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (97-3112-B-001-020)
- Chang Gung Memorial Hospital
This publication has 34 references indexed in Scilit:
- Psoriasis genetics: breaking the barrierTrends in Genetics, 2010
- Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G2/M TransitionJournal of Biological Chemistry, 2010
- Complementary therapy for atopic dermatitis and other allergic skin diseases: facts and controversiesClinics in Dermatology, 2010
- Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active componentJournal of Dermatological Science, 2009
- Genome-wide association scan yields new insights into the immunopathogenesis of psoriasisGenes & Immunity, 2009
- Clinical Spectrum and Severity of PsoriasisCurrent problems in dermatology, 2009
- Clinical Assessment of Patients With Recalcitrant Psoriasis in a Randomized, Observer-Blind, Vehicle-Controlled Trial Using Indigo NaturalisArchives of Dermatology, 2008
- The Efficacy and Safety of Topically Applied Indigo Naturalis Ointment in Patients with Plaque-Type PsoriasisDermatology, 2007
- Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancerOncogene, 2003
- Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancerCancer Letters, 2001